Jci_page_head_homepage_01 Jci_page_head_homepage_02
Silvana Obici, Zhaohui Feng, Jianzhen Tan, LiSen Liu, George Karkanias, Luciano Rossetti
Published in Volume 108, Issue 7
J Clin Invest. 2001; 108(7):1079–1085 doi:10.1172/JCI12954
Abstract | Full text | PDF
Options: View larger image (or click on image)
Medium
Figure 3

Effect of α-MSH and SHU9119 administration on subcutaneous and visceral fat. (a) Weight of epidydimal, omental, and perirenal fat depots in the four experimental groups. (b) Total visceral fat mass represents the sum of omental, epididymal, and perirenal fat depots. (c) Subcutaneous fat mass was estimated by subtracting the total visceral fat from the whole body fat mass. Of note, administration of α-MSH selectively decreased the size of all visceral fat depots compared with SHU-PF, despite similar food intake, weight changes, and subcutaneous fat mass. Values represent mean ± SE. *P < 0.01 vs. vehicle.